Autoimmune disease after autologous hematopoietic stem cell transplantation

被引:36
作者
Bohgaki, Toshiyuki [1 ]
Atsumi, Tatsuya [1 ]
Koike, Takao [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan
关键词
hematopoietic stem cell transplantation; immune reconstitution; autoimmune disease;
D O I
10.1016/j.autrev.2007.11.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hematopoietic stem cell transplantation (HSCT) is an effective treatment for refractory autoimmune diseases. The safety and long-term outcome have been also acceptable. Infectious diseases under immune suppressive state after autologous HSCT are common transplantation related complications whereas autoimmune diseases are uncommon. Organ specific autoimmune diseases, such as immune mediated thrombocytopenia and thyroid dysfunction, are the most common after autologous HSCT. Systemic autoimmune diseases can also develop after autologous HSCT in patients with hematological disorders with genetic predisposition to autoimmune diseases. Although the mechanism of autoimmunity after HSCT is not well-known, long-term follow-up is essential in patients with autoimmune diseases treated with autologous HSCT. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 32 条
[21]   Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma [J].
Koike, K ;
Kohda, K ;
Kuga, T ;
Nakazawa, O ;
Ando, M ;
Takayanagi, N ;
Matsunaga, T ;
Sakamaki, S ;
Niitsu, Y .
BONE MARROW TRANSPLANTATION, 2001, 28 (06) :619-621
[22]   Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used [J].
Loh, Yvonne ;
Oyama, Yu ;
Statkute, Laisvyde ;
Quigley, Kathleen ;
Yaung, Kimberly ;
Gonda, Elizabeth ;
Barr, Walter ;
Jovanovic, Borko ;
Craig, Robert ;
Stefoski, Dusan ;
Cohen, Bruce ;
Burt, Richard K. .
BLOOD, 2007, 109 (06) :2643-2648
[23]  
MINCHINTON RM, 1984, CLIN LAB HAEMATOL, V6, P157
[24]   Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients [J].
Muraro, PA ;
Douek, DC ;
Packer, A ;
Chung, K ;
Guenaga, FJ ;
Cassiani-Ingoni, R ;
Campbell, C ;
Memon, S ;
Nagle, JW ;
Hakim, FT ;
Gress, RE ;
McFarland, HF ;
Burt, RK ;
Martin, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :805-816
[25]   Allogeneic marrow transplantation in patients with severe systemic sclerosis - Resolution of dermal fibrosis [J].
Nash, Richard A. ;
McSweeney, Peter A. ;
Nelson, J. Lee ;
Wener, Mark ;
Georges, George E. ;
Langston, Amelia A. ;
Shulman, Howard ;
Sullivan, Keith M. ;
Lee, Julie ;
Henstorf, Gretchen ;
Storb, Rainer ;
Furst, Daniel E. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1982-1986
[26]   High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus [J].
Petri, M ;
Jones, RJ ;
Brodsky, RA .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :166-173
[27]   Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database [J].
Saccardi, R. ;
Kozak, T. ;
Bocelli-Tyndall, C. ;
Fassas, A. ;
Kazis, A. ;
Havrdov, E. ;
Carreras, E. ;
Saiz, A. ;
Lowenberg, B. ;
te Boekhorst, P. A. W. ;
Gualandi, F. ;
Openshaw, H. ;
Longo, G. ;
Pagliai, F. ;
Massacesi, L. ;
Deconink, E. ;
Ouyang, J. ;
Nagore, F. J. Z. ;
Besalduch, J. ;
Lisukov, I. A. ;
Bonini, A. ;
Merelli, E. ;
Slavin, S. ;
Gratwahl, A. ;
Passweg, J. ;
Tyndall, A. ;
Steck, A. J. ;
Andolina, M. ;
Capobianco, M. ;
Martin, J. L. D. ;
Lugaresi, A. ;
Meucci, G. ;
Saez, R. A. ;
Clark, R. E. ;
Fernandez, M. N. ;
Fouillard, L. ;
Herstenstein, B. ;
Koza, V. ;
Cocco, E. ;
Baurmann, H. ;
Mancardi, G. L. .
MULTIPLE SCLEROSIS, 2006, 12 (06) :814-823
[28]   Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature [J].
Shaw, B ;
Mehta, AB .
CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (06) :385-387
[29]   Autoimmune diseases and autoimmunity post-bone marrow transplantation [J].
Sherer, Y ;
Shoenfeld, Y .
BONE MARROW TRANSPLANTATION, 1998, 22 (09) :873-881
[30]   Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study [J].
Traynor, AE ;
Schroeder, J ;
Rosa, RM ;
Cheng, D ;
Stefka, J ;
Mujais, S ;
Baker, S ;
Burt, RK .
LANCET, 2000, 356 (9231) :701-707